(NASDAQ: BNOX) Bionomics Limited's forecast annual revenue growth rate of 22,893.66% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 246.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Bionomics Limited's revenue in 2024 is $14,504.On average, 2 Wall Street analysts forecast BNOX's revenue for 2024 to be $6,419,236,161, with the lowest BNOX revenue forecast at $1,828,568,022, and the highest BNOX revenue forecast at $11,009,904,300.
In 2025, BNOX is forecast to generate $11,009,904,300 in revenue, with the lowest revenue forecast at $11,009,904,300 and the highest revenue forecast at $11,009,904,300.